Talphera (TLPH) Retained Earnings (2010 - 2026)
Talphera (TLPH) posted quarterly Retained Earnings of $492.5 million for Q1 2026, up 207.11% year-over-year from $160.4 million in Q1 2025, and up 0.82% quarter-over-quarter from $488.5 million in Q4 2025.
Talphera (TLPH) Retained Earnings (2010 - 2026) Analysis & Trends
Talphera's Retained Earnings history runs 17 years deep, the most recent figure standing at $492.5 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 207.11% year-over-year to $492.5 million; the TTM figure through Mar 2026 stood at $492.5 million (up 207.11% YoY), while the FY2025 annual figure was $488.5 million, up 206.84% from the prior year.
- Retained Earnings for Q1 2026 stood at $492.5 million, up from $488.5 million in the prior quarter.
- The five-year high for Retained Earnings was $492.5 million in Q1 2026, with the low at -$482.3 million in Q1 2022.
- The 5-year median for Retained Earnings is $448.2 million (2023), against an average of $91.0 million.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings sank 214.82% in 2022, then jumped 207.63% in 2023.
- Talphera's Retained Earnings stood at -$425.8 million in 2022, then surged by 207.63% to $458.3 million in 2023, then sank by 199.76% to -$457.2 million in 2024, then soared by 206.84% to $488.5 million in 2025, then rose by 0.82% to $492.5 million in 2026.
- Business Quant data shows TLPH's Retained Earnings at $492.5 million in Q1 2026, $488.5 million in Q4 2025, and $486.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.75 Bn |
| 10 | Talphera | 90.35 Mn | 90.35 Mn | - | 492.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 492.74 Mn |
| Mar 31, 2026 | 492.50 Mn |
| Dec 31, 2025 | 488.51 Mn |
| Sep 30, 2025 | 486.88 Mn |
| Jun 30, 2025 | 469.92 Mn |
| Mar 31, 2025 | -459.82 Mn |
| Dec 31, 2024 | -457.23 Mn |
| Sep 30, 2024 | -455.36 Mn |
| Jun 30, 2024 | 464.72 Mn |
| Mar 31, 2024 | 464.50 Mn |
| Dec 31, 2023 | 458.31 Mn |
| Sep 30, 2023 | 458.00 Mn |
| Jun 30, 2023 | -438.35 Mn |
| Mar 31, 2023 | 448.21 Mn |
| Dec 31, 2022 | -425.83 Mn |
| Sep 30, 2022 | 445.56 Mn |
| Jun 30, 2022 | -411.60 Mn |
| Mar 31, 2022 | -482.26 Mn |
| Dec 31, 2021 | 437.68 Mn |
| Sep 30, 2021 | -465.67 Mn |